Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Mol Cancer Res. 2021 Mar 16;19(6):957–967. doi: 10.1158/1541-7786.MCR-20-0825

Figure 2.

Figure 2

A) Schematic depiction of the fractionation strategy used to determine the fraction of SFK molecules in each of the four possible Y416 and Y527 phosphorylated and non-phosphorylated regulatory states. B) The distribution of SFKs in the four possible regulatory states is shown for the indicated cell lines.